Equity Profile

SNN

Smith & Nephew plc

Health CareHealth Care Equipment$13.1B

Feb6Thu

Pre-Earnings Brief

UpcomingQ3-2019Pre-Market9:00 AM EST

Company Snapshot

Smith & Nephew plc (SNN) is a global medical technology company that specializes in advanced wound management, surgical devices, and orthopedic reconstruction. As a player in the health care sector, it is positioned to benefit from trends in aging populations and increasing demand for innovative medical solutions.

Key Metrics to Watch

Revenue Growth

Investors will be keen to see if Smith & Nephew can maintain or improve its revenue growth amid competitive pressures.

N/A

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will help gauge the company's financial health.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SNN Q3-2019 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

+19.92%

Avg Stock Reaction

+0.05%

Last Quarter Recap

In the last quarter, Smith & Nephew reported an EPS of $0.92, showing a stable performance compared to previous quarters. The stock reacted positively, gaining 1.23% the following day.

Management Promises & Guidance

Focus on expanding product lines in advanced wound care.
Commitment to improving operational efficiency.
Plans to enhance market presence in emerging markets.

Expectations

Wall Street Expectations

Overall, expectations are mixed as analysts await clarity on revenue growth and profitability. The stock's implied volatility suggests that investors are bracing for significant movement post-earnings.

Bull Case

If Smith & Nephew can report strong revenue growth and improved margins, it could signal a robust recovery and attract more investors.

Bear Case

Conversely, if the company fails to meet revenue expectations or shows signs of market share loss, it could lead to a sharp decline in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the revenue growth rate for the advanced wound management segment?

This metric will be crucial in assessing the company's ability to compete and grow in a key market.

How has Smith & Nephew's market share changed in the last quarter?

Changes in market share can indicate the effectiveness of the company's strategies and its competitive standing.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Smith & Nephew's potential for revenue growth in emerging markets, which could offset competitive pressures.

Supporting Evidence

The company's recent investments in innovation could lead to stronger product offerings.

Historical patterns show that the stock has reacted positively to previous earnings beats, suggesting potential for upside.

Options pricing indicates that investors are anticipating a larger move than historical averages, hinting at underlying bullish sentiment.

Key Risk

If the revenue growth in emerging markets exceeds expectations, it could challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around the company's ability to sustain growth in a competitive landscape.

Bull Confirmed If

A revenue growth rate of over 10% in the advanced wound management segment would confirm the bull case.

Bear Confirmed If

A decline in market share or revenue growth below 5% would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±32.33%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a significant potential price movement, indicating that investors are anticipating volatility around the earnings report.

Options are pricing ±32.3% while SNN has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

28.2%

Calls (300)P/C Ratio: 0.10Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Smith & Nephew beats expectations, history suggests the stock could rise by around 2.38% on average, confirming a positive outlook.

In-Line / Cautious

A cautious in-line report may lead to minimal movement, as investors digest management's commentary on future prospects.

Miss

If the company misses expectations, history suggests a potential decline of about 1.11%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product launches in advanced wound management.
2Insights into operational efficiency improvements.
3Details on market share changes in key segments.
4Management's outlook on emerging market growth.
5Responses to competitive pressures in the health care equipment sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Kennametal Inc.

Company Snapshot

Key Metrics to Watch

Revenue Growth

Investors will be keen to see if Smith & Nephew can maintain or improve its revenue growth amid competitive pressures.

N/A

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will help gauge the company's financial health.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SNN Q3-2019 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

+19.92%

Avg Stock Reaction

+0.05%

Last Quarter Recap

In the last quarter, Smith & Nephew reported an EPS of $0.92, showing a stable performance compared to previous quarters. The stock reacted positively, gaining 1.23% the following day.

Management Promises & Guidance

Focus on expanding product lines in advanced wound care.
Commitment to improving operational efficiency.
Plans to enhance market presence in emerging markets.

Expectations

Wall Street Expectations

Bull Case

If Smith & Nephew can report strong revenue growth and improved margins, it could signal a robust recovery and attract more investors.

Bear Case

Conversely, if the company fails to meet revenue expectations or shows signs of market share loss, it could lead to a sharp decline in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the revenue growth rate for the advanced wound management segment?

This metric will be crucial in assessing the company's ability to compete and grow in a key market.

How has Smith & Nephew's market share changed in the last quarter?

Changes in market share can indicate the effectiveness of the company's strategies and its competitive standing.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Smith & Nephew's potential for revenue growth in emerging markets, which could offset competitive pressures.

Supporting Evidence

The company's recent investments in innovation could lead to stronger product offerings.

Historical patterns show that the stock has reacted positively to previous earnings beats, suggesting potential for upside.

Options pricing indicates that investors are anticipating a larger move than historical averages, hinting at underlying bullish sentiment.

Key Risk

If the revenue growth in emerging markets exceeds expectations, it could challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around the company's ability to sustain growth in a competitive landscape.

Bull Confirmed If

A revenue growth rate of over 10% in the advanced wound management segment would confirm the bull case.

Bear Confirmed If

A decline in market share or revenue growth below 5% would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±32.33%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a significant potential price movement, indicating that investors are anticipating volatility around the earnings report.

Options are pricing ±32.3% while SNN has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

28.2%

Calls (300)P/C Ratio: 0.10Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Smith & Nephew beats expectations, history suggests the stock could rise by around 2.38% on average, confirming a positive outlook.

In-Line / Cautious

A cautious in-line report may lead to minimal movement, as investors digest management's commentary on future prospects.

Miss

If the company misses expectations, history suggests a potential decline of about 1.11%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product launches in advanced wound management.
2Insights into operational efficiency improvements.
3Details on market share changes in key segments.
4Management's outlook on emerging market growth.
5Responses to competitive pressures in the health care equipment sector.